BioSpace News Archive

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and Trademark Office (“US PTO”) has granted the patent regarding the Rapid Pathogen Infectious Disease Liquid Biopsy Diagnostics (“RPIDD”) regarding the invention of an unbiased and simultaneous amplification method for DNA library preparation (US Patent No : US11,280,028 B1) to A*STAR institution.

Growth of pharmaceutical and food industries is one of the major factors driving market revenue growth.

Growing demand for minimally invasive procedures and increasing incidence of respiratory disorders are some key factors driving market revenue growth of the bronchoscopy market.

Saniona, a clinical-stage biopharmaceutical company focused on rare diseases, announced that it will refocus its strategy on ion channel research and development and, as a result, further streamline its operations.

Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, has appointed Michael Klichinsky, PharmD, PhD, to the role of Chief Scientific Officer.

- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing.

The global biotechnology market size is expected to be worth around US$ 3.44 trillion by 2030 from valued at US$ 852.88 billion in 2020 and is anticipated to grow at a CAGR of 17.83% during forecast period 2021 to 2030.

The global medical device regulatory affairs market size is expected to be worth around US$ 11.6 billion by 2030 from valued at US$ 5.5 billion in 2020, growing at a CAGR of 10.6% during forecast period 2021 to 2030.

According to Report, the global eclinical solutions market size is predicted to surpass around USD 20.8 billion by 2030 from valued at USD 6.2 billion in 2020, registering a CAGR of 12.6% from 2022 to 2030.

According to Report, the global sinus dilation device market size is expected to surpass around US$ 8.6 billion by 2030 from valued at US$ 2.7 billion in 2020 and expanding growth at a CAGR of 15% from 2021 to 2030.